GGT1 and peritoneum cancer: GGT is purportedly overexpressed in several human cancers, such as breast, ovarian, brain, lung, colon, and peritoneum cancers, as well as head and neck squamous cell carcinoma, and methods exploiting gGlu-HMRG and GGT have been applied to detect such cancers [4–11].